Patients taking GLP-1 receptor agonists should have regular cardiovascular check-ups to ensure their safety and achieve the best possible outcomes
These conditions require careful management, and introducing a treatment that impacts the circulatory system could create unnecessary risks
After excluding individuals with pre-existing neurodegenerative or cerebrovascular disease, the study compared 30,430 patients using GLP-1RA therapy (semaglutide or tirzepatide) with 30,430 patients prescribed other antidiabetic agentsincluding biguanides, sulfonylureas, dipeptidyl peptidase 4 inhibitors, and sodium-glucose cotransporter 2 inhibitorsusing propensity score matching to control for baseline differences
Is a refrigerator available in my room or could one be provided? You are not required to disclose your diagnosis, medication name, or treatment purpose
& Harris, A
Here are common impacts GLP-1 users face and the supplements that can help make for a healthier weight-loss journey